Quanticate Sponsors PhD Research into Response-Adaptive Trial Design


Applied Clinical Trials

Quanticate, a data-focused CRO, has announced that it is partnering with Lancaster University to sponsor a STOR-i PhD project. The partnership will support research into optimizing clinical trial design for rare disease and the role of response-adaptive randomization.

Read the full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.